ClinicalTrials.gg
RecruitingNCT07406516TENVOLUpdated Sep 21, 2026

Identification of Kinematic Variables Specific of Patellar Tendinopathy in Athletes at Risk

An interventional study of The intervention consists of a series of vertical jump tests captured using high-resolution cameras with markerless motion capture technology. and The intervention consists of a series of vertical jump tests captured using high-resolution cameras with markerless motion capture technology at 6 months and 12 months in Patellar Tendinitis, Jumper's Knee and Musculoskeletal Injuries, sponsored by University Hospital, Montpellier. Recruiting at 1 site in France. Open to male participants aged 18 Years to 45 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-09-21.

Sponsored by University Hospital, Montpellier · Not applicable, Interventional, and Prevention

From the registry’s dates

  • Started Sep 2026; still recruiting 1 month later.
Phase
Not applicable
Study type
Interventional
Enrollment
60
Allocation
Non-randomized
Ages
18 Years to 45 Years
Sex
Male
01

Study summary

This research aims to identify and monitor specific kinematic markers associated with patellar tendinopathy in athletes at risk. Using a markerless motion capture system, vertical jump tests will be analyzed to detect early biomechanical changes in the knees, hips, trunk, and ankles. By comparing injured participants, the study seeks to improve early diagnosis and personalized prevention strategies for patellar tendinopathy.

Read the detailed description

Patellar tendinopathy, also known as Jumper's knee, is the most common pathology in elite sports, with 30% of diagnoses occurring in volleyball. Among elite volleyball players, the prevalence of this overuse-related condition ranges between 40% and 50%, resulting in anterior knee pain during daily and recreational activities, which can lead to deficits in strength and sports performance. To date, investigator can determine whether a patient has had a history of tendinopathy through modifications in biomechanical jump-landing strategies. However, there is a lack of early biomechanical markers to identify the onset of patellar tendinopathy and thus prevent its chronic progression. A preventive strategy using markerless motion capture technology, providing quantitative and visual feedback of a 3D human body model, shows promise. Investigators hypothesize that jump-landing kinematic analysis using markerless technology could identify early kinematic markers specific to patellar tendinopathy, distinguishing affected individuals from a non-tendinopathy population. This could ultimately help identify motor strategies following the onset of patellar tendinopathy A prospective longitudinal multicenter cohort. After signing the consent form, participants will undergo a medical examination, including a clinical assessment, a SLDS test, a Doppler ultrasound of the patellar tendon, and evaluation using the VISA-PF and OSTRC-P scores. Following a standardized 10-minute warm-up, participants will perform vertical jump tests captured by high-resolution cameras, analyzed using markerless motion capture technology. These assessments will be conducted at inclusion and at 3, 6, 9, and 12 months. Additional medical visits will occur if symptoms arise outside of testing.

02

Conditions studied

  • Patellar Tendinitis
  • Jumper's Knee
  • Musculoskeletal Injuries
  • Knee Injuries

Keywords

  • patellar tendinopathy
  • injury
  • Jumper's knee
  • Biomechanical variables
  • Biomechanical modeling
  • Measurement in an ecological environment
  • Profiling
  • Markerless technology
03

In context

Knee Injuries

267 studies on the registry are indexed under Knee Injuries; 59 are open to participants now.

This study's planned enrollment of 60 is above the median of 49 across 178 interventional studies indexed under Knee Injuries.

Browse Knee Injuries studies →

Lead sponsor

University Hospital, Montpellier is the lead sponsor of 1,261 studies on the registry; 224 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 45 Years
Sexes eligible
Male
Accepts healthy volunteers
Yes

Eligibility criteria

  • Subject aged between 18 and 45 years
  • Male subject
  • Regularly participating in physical activity involving jumping (a predisposing factor for patellar tendinopathy) twice a week for at least one year.
  • Participants affiliated with or covered by a social security scheme

SPECIFIC INCLUSION CRITERIA FOR THE PATELLAR TENDINOPATHY GROUP

Patients with at least 2 of the following 3 criteria:

  • Modified Öhberg score ≥2 according to L Öhberg, H Alfredson (2002)
  • VISA-PF \< 80/100 according to Kaux et al. (2016) and/or OSTRC P ≥ 6/100 according to Owoeye et al. (2018)
  • Single Leg Decline Squat (SLDS): VAS ≥ 1/10 with pain mapping at the patellar tendon; according to Coombes et al. (2020)

SPECIFIC INCLUSION CRITERIA FOR THE HEALTHY GROUP

Patients with 0 or 1 of the following 3 criteria:

  • Modified Öhberg score ≥2 according to L Öhberg, H Alfredson (2002)
  • VISA-PF \< 80/100 according to Kaux et al. (2016) and/or OSTRC P ≥ 6/100 according to Owoeye et al. (2018)
  • Single Leg Decline Squat (SLDS): VAS ≥ 1/10 with pain mapping at the patellar tendon; according to Coombes et al. (2020)

Non inclusion Criteria:

  • Significant medical and surgical history involving the lower limbs (e.g., ACL ligament reconstruction, meniscectomy, etc.)
  • to participating in sports activities
  • Other pathologies involving the lower limbs (\< 6 months), e.g., torn knee ligaments, ankle sprain, knee sprain, etc.
  • Participants who have not given their
  • Participants subject to legal protection measures (legal guardianship, conservatorship, curatorship)
  • Participants deprived of their liberty by judicial or administrative decision
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Contraindication

A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Non-randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
60 participants (estimated)

Study arms

  • Experimental
    patellar tendinopathy group

    Diagnostic Test: The intervention consists of a series of vertical jump tests captured using high-resolution cameras with markerless motion capture technology.

    Diagnostic Test: The intervention consists of a series of vertical jump tests captured using high-resolution cameras with markerless motion capture technology.

  • Other
    healthy group

    Diagnostic Test: The intervention consists of a series of vertical jump tests captured using high-resolution cameras with markerless motion capture technology.

    Diagnostic Test: The intervention consists of a series of vertical jump tests captured using high-resolution cameras with markerless motion capture technology at 6 months and 12 months

Interventions

  • Diagnostic testThe intervention consists of a series of vertical jump tests captured using high-resolution cameras with markerless motion capture technology.

    Participants will undergo clinical evaluations including the Single Leg Decline Squat (SLDS) test, VISA-PF, OSTRC-P questionnaires, and Doppler ultrasound of the patellar tendon. These assessments will take place at baseline (T0) and follow-up periods (M3, M6, M9, M12) to track the evolution of kinematic markers and clinical symptoms related to patellar tendinopathy.

  • Diagnostic testThe intervention consists of a series of vertical jump tests captured using high-resolution cameras with markerless motion capture technology at 6 months and 12 months

    Participants will undergo clinical evaluations including the Single Leg Decline Squat (SLDS) test, VISA-PF, OSTRC-P questionnaires, and Doppler ultrasound of the patellar tendon. These assessments will take place at baseline (T0) and follow-up periods ( M6 et M12) to track the evolution of kinematic markers and clinical symptoms related to patellar tendinopathy.

06

What researchers measure

Primary outcomes

  1. Variations of knee flexion angle at initial contact at 3 months (only for patients in the patellar tendinopathy group)

    The participant will perform the required vertical jump tests. The kinematic data will be captured by the investigating physical therapist specializing in motion analysis using a camera and markerless technology.

    Time frame: Between the initial visit and the 3-month visit

  2. Variations of knee flexion angle at initial contact at 6 months

    The participant will perform the required vertical jump tests. The kinematic data will be captured by the investigating physical therapist specializing in motion analysis using a camera and markerless technology.

    Time frame: Between the 3-month visit and the 6-month visit

  3. Variations of knee flexion angle at initial contact at 9 months (only for patients in the patellar tendinopathy group)

    The participant will perform the required vertical jump tests. The kinematic data will be captured by the investigating physical therapist specializing in motion analysis using a camera and markerless technology.

    Time frame: Between the 6-month visit and the 9-month visit

  4. Variations of knee flexion angle at initial contact at 12 months

    The participant will perform the required vertical jump tests. The kinematic data will be captured by the investigating physical therapist specializing in motion analysis using a camera and markerless technology.

    Time frame: Between the 9-month visit and the 12-month visit

  5. Variations of the maximum knee flexion angle at 3 months (only for patients in the patellar tendinopathy group)

    The participant will perform the required vertical jump tests. The kinematic data will be captured by the investigating physical therapist specializing in motion analysis using a camera and markerless technology.

    Time frame: Between the initial visit and the 3-month visit

  6. Variations of the maximum knee flexion angle at 6 months

    The participant will perform the required vertical jump tests. The kinematic data will be captured by the investigating physical therapist specializing in motion analysis using a camera and markerless technology.

    Time frame: Between the 3-month visit and the 6-month visit

  7. Variations of the maximum knee flexion angle at 9 months (only for patients in the patellar tendinopathy group)

    The participant will perform the required vertical jump tests. The kinematic data will be captured by the investigating physical therapist specializing in motion analysis using a camera and markerless technology.

    Time frame: Between the 6-month visit and the 9-month visit

  8. Variations of the maximum knee flexion angle at 12 months

    The participant will perform the required vertical jump tests. The kinematic data will be captured by the investigating physical therapist specializing in motion analysis using a camera and markerless technology.

    Time frame: Between the 9-month visit and the 12-month visit

  9. Variations of the range of motion (ROM) of the knee between initial contact and maximum flexion angle at 3 months (only for patients in the patellar tendinopathy group)

    The participant will perform the required vertical jump tests. The kinematic data will be captured by the investigating physical therapist specializing in motion analysis using a camera and markerless technology.

    Time frame: Between the initial visit and the 3-month visit

  10. Variations of the range of motion (ROM) of the knee between initial contact and maximum flexion angle at 6 months

    The participant will perform the required vertical jump tests. The kinematic data will be captured by the investigating physical therapist specializing in motion analysis using a camera and markerless technology.

    Time frame: Between the 3-month visit and the 6-month visit

  11. Variations of the range of motion (ROM) of the knee between initial contact and maximum flexion angle at 9 months (only for patients in the patellar tendinopathy group)

    The participant will perform the required vertical jump tests. The kinematic data will be captured by the investigating physical therapist specializing in motion analysis using a camera and markerless technology.

    Time frame: Between the 6-month visit and the 9-month visit

  12. Variations of the range of motion (ROM) of the knee between initial contact and maximum flexion angle at 12 months

    The participant will perform the required vertical jump tests. The kinematic data will be captured by the investigating physical therapist specializing in motion analysis using a camera and markerless technology.

    Time frame: Between the 9-month visit and the 12-month visit

  13. Variations of the angle at the peak of the vertical ground reaction force (VGRF) at 3 months (only for patients in the patellar tendinopathy group)

    The participant will perform the required vertical jump tests. The kinematic data will be captured by the investigating physical therapist specializing in motion analysis using a camera and markerless technology.

    Time frame: Between the initial visit and the 3-month visit

  14. Variations of the angle at the peak of the vertical ground reaction force (VGRF)at 6 months

    The participant will perform the required vertical jump tests. The kinematic data will be captured by the investigating physical therapist specializing in motion analysis using a camera and markerless technology.

    Time frame: Between the 3-month visit and the 6-month visit

  15. Variations of the angle at the peak of the vertical ground reaction force (VGRF) at 9 months (only for patients in the patellar tendinopathy group)

    The participant will perform the required vertical jump tests. The kinematic data will be captured by the investigating physical therapist specializing in motion analysis using a camera and markerless technology.

    Time frame: Between the 6-month visit and the 9-month visit

  16. Variations of the angle at the peak of the vertical ground reaction force (VGRF) at 12 months

    The participant will perform the required vertical jump tests. The kinematic data will be captured by the investigating physical therapist specializing in motion analysis using a camera and markerless technology.

    Time frame: Between the 9-month visit and the 12-month visit

  17. Comparison of variation between healthy group and patellar tendinopathy group of knee flexion angle at initial contact at 6 months

    The participant will perform the required vertical jump tests. The kinematic data will be captured by the investigating physical therapist specializing in motion analysis using a camera and markerless technology.

    Time frame: Between the two 6-month visits of the two groups

  18. Comparison between the healthy group and the patellar tendinopathy group of variation of the maximum knee flexion angle at 6 months

    The participant will perform the required vertical jump tests. The kinematic data will be captured by the investigating physical therapist specializing in motion analysis using a camera and markerless technology.

    Time frame: Between the two 6-month visits of the two groups

  19. Comparison between the healthy group and the patellar tendinopathy group of variations of the range of motion (ROM) of the knee between initial contact and maximum flexion angle at 6 months

    The participant will perform the required vertical jump tests. The kinematic data will be captured by the investigating physical therapist specializing in motion analysis using a camera and markerless technology.

    Time frame: Between the two 6-month visits of the two groups

  20. Comparison between the healthy group and the patellar tendinopathy group of variations of the angle at the peak of the vertical ground reaction force (VGRF)at 6 months

    The participant will perform the required vertical jump tests. The kinematic data will be captured by the investigating physical therapist specializing in motion analysis using a camera and markerless technology.

    Time frame: Between the two 6-month visits of the two groups

Secondary outcomes

  1. Variations of the angle of flexion of the trunk, hips, knees, and ankles at initial contact at 3 months (only for patients in the patellar tendinopathy group)

    The participant will perform the required vertical jump tests. The kinematic data will be captured by the investigating physical therapist specializing in motion analysis using a camera and markerless technology.

    Time frame: Between the initial visit and the 3-month visit

  2. Variations of the angle of flexion of the trunk, hips, knees, and ankles at initial contact at 6 months

    The participant will perform the required vertical jump tests. The kinematic data will be captured by the investigating physical therapist specializing in motion analysis using a camera and markerless technology.

    Time frame: Between the 3-month visit and the 6-month visit

  3. Variations of the angle of flexion of the trunk, hips, knees, and ankles at initial contact at 9 months (only for patients in the patellar tendinopathy group)

    The participant will perform the required vertical jump tests. The kinematic data will be captured by the investigating physical therapist specializing in motion analysis using a camera and markerless technology.

    Time frame: Between the 6-month visit and the 9-month visit

  4. Variations of the angle of flexion of the trunk, hips, knees, and ankles at initial contact at 12 months

    The participant will perform the required vertical jump tests. The kinematic data will be captured by the investigating physical therapist specializing in motion analysis using a camera and markerless technology.

    Time frame: Between the 9-month visit and the 12-month visit

  5. Variations of the maximum flexion angle of the trunk, hips, knees, and ankles upon landing at 3 months (only for patients in the patellar tendinopathy group)

    The participant will perform the required vertical jump tests. The kinematic data will be captured by the investigating physical therapist specializing in motion analysis using a camera and markerless technology.

    Time frame: Between the initial visit and the 3-month visit

  6. Variations of the maximum flexion angle of the trunk, hips, knees, and ankles upon landing at 6 months

    The participant will perform the required vertical jump tests. The kinematic data will be captured by the investigating physical therapist specializing in motion analysis using a camera and markerless technology.

    Time frame: Between the 3-month visit and the 6-month visit

  7. Variations of the maximum flexion angle of the trunk, hips, knees, and ankles upon landing at 9 months (only for patients in the patellar tendinopathy group)

    The participant will perform the required vertical jump tests. The kinematic data will be captured by the investigating physical therapist specializing in motion analysis using a camera and markerless technology.

    Time frame: Between the 6-month visit and the 9-month visit

  8. Variations of the maximum flexion angle of the trunk, hips, knees, and ankles upon landing at 12 months

    The participant will perform the required vertical jump tests. The kinematic data will be captured by the investigating physical therapist specializing in motion analysis using a camera and markerless technology.

    Time frame: Between the 9-month visit and the 12-month visit

  9. Variations of the range of motion (ROM) of the trunk, hips, knees, and ankles between initial contact and maximum flexion angle upon landing at 3 months (only for patients in the patellar tendinopathy group)

    The participant will perform the required vertical jump tests. The kinematic data will be captured by the investigating physical therapist specializing in motion analysis using a camera and markerless technology.

    Time frame: Between the initial visit and the 3-month visit

  10. Variations of the range of motion (ROM) of the trunk, hips, knees, and ankles between initial contact and maximum flexion angle upon landing at 6 months

    The participant will perform the required vertical jump tests. The kinematic data will be captured by the investigating physical therapist specializing in motion analysis using a camera and markerless technology.

    Time frame: Between the 3-month visit and the 6-month visit

  11. Variations of the range of motion (ROM) of the trunk, hips, knees, and ankles between initial contact and maximum flexion angle upon landing at 9 months (only for patients in the patellar tendinopathy group)

    The participant will perform the required vertical jump tests. The kinematic data will be captured by the investigating physical therapist specializing in motion analysis using a camera and markerless technology.

    Time frame: Between the 6-month visit and the 9-month visit

  12. Variations of the range of motion (ROM) of the trunk, hips, knees, and ankles between initial contact and maximum flexion angle upon landing at 12 months

    The participant will perform the required vertical jump tests. The kinematic data will be captured by the investigating physical therapist specializing in motion analysis using a camera and markerless technology.

    Time frame: Between the 9-month visit and the 12-month visit

  13. Variations of the angle at the peak of the vertical ground reaction force (VGRF) of the hips, knees, and ankles upon landing at 3 months (only for patients in the patellar tendinopathy group)

    The participant will perform the required vertical jump tests. The kinematic data will be captured by the investigating physical therapist specializing in motion analysis using a camera and markerless technology.

    Time frame: Between the initial visit and the 3-month visit

  14. Variations of the angle at the peak of the vertical ground reaction force (VGRF) of the hips, knees, and ankles upon landing at 6 months

    The participant will perform the required vertical jump tests. The kinematic data will be captured by the investigating physical therapist specializing in motion analysis using a camera and markerless technology.

    Time frame: Between the 3-month visit and the 6-month visit

  15. Variations of the angle at the peak of the vertical ground reaction force (VGRF) of the hips, knees, and ankles upon landing at 9 months (only for patients in the patellar tendinopathy group)

    The participant will perform the required vertical jump tests. The kinematic data will be captured by the investigating physical therapist specializing in motion analysis using a camera and markerless technology.

    Time frame: Between the 6-month visit and the 9-month visit

  16. Variations of the angle at the peak of the vertical ground reaction force (VGRF) of the hips, knees, and ankles upon landing at 12 months

    The participant will perform the required vertical jump tests. The kinematic data will be captured by the investigating physical therapist specializing in motion analysis using a camera and markerless technology.

    Time frame: Between the 9-month visit and the 12-month visit

07

Study locations

1 of 1 sites recruiting
  • Sports Medicine and Traumatology LAPEYRONIE Hospital - Montpellier University Hospital
    Montpellier, France
    Recruiting
08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Sep 21, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07406516
Responsible party
Sponsor
First posted
Feb 12, 2026
Start date
Sep 15, 2026
Primary completion
May 1, 2029 (estimated)
Completion
May 1, 2029 (estimated)
Last update
Sep 21, 2026

Study contacts

Benjamin BEN ZAKI
Contact
b-benzaki@chu-montpellier.fr
+336 66 09 13 43

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion